Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2025 08:01 ET | Source: Vaxxas Pty Ltd

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...
December 11, 2025 07:07 ET | Source: Keiretsu Forum Mid-Atlantic

Keiretsu Forum and MDB Capital Close 2025 With High-Impact Investor Summits, and Announces Expanded Summit Series for 2026

Keiretsu Forum MST and MDB Capital united 150+ investors to improve syndication and exits, and will expand the Investor Summit series nationwide in 2026.
December 09, 2025 09:30 ET | Source: Medical Microinstruments, Inc.

MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani

MMI today announced that it received U.S. Food and Drug Administration 510(k) clearance for its NanoWrist® Scissors and Forceps indicated for soft tissue.
December 05, 2025 07:06 ET | Source: Keiretsu Forum Mid-Atlantic

New VP Hire Signals Exit-Focused Push for Angels Seeking Faster Liquidity

Keiretsu MST hires Juan Arango to standardize diligence and syndication, driving faster, structured exits, syndication, IPO Angels, and other channels.
December 01, 2025 09:00 ET | Source: Medical Microinstruments, Inc.

MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential

MMI, today announced that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT®) code for lymphovenous bypass.
December 01, 2025 07:00 ET | Source: NeurAxis, Inc.

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 26, 2025 07:29 ET | Source: Research and Markets

Medical Device Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 903 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
November 24, 2025 01:30 ET | Source: ONWARD Medical NV

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025

EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,...
November 18, 2025 13:38 ET | Source: PrognomiQ

UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer

PrognomiQ launches ProVue Lung, a novel proteomics-based Laboratory Developed Test (LDT) to help improve detection of lung cancer at its earliest stages.
November 17, 2025 01:30 ET | Source: ONWARD Medical NV

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX® System both in...